Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Risk factors for treatment failure of heated humidified high-flow nasal cannula as an initial respiratory support in newborn infants with respiratory distress

Authors
Lee, Won YoungChoi, Eui KyungShin, JeongheeLee, Eun HeeChoi, Byung MinHong, Young Sook
Issue Date
4월-2020
Publisher
ELSEVIER TAIWAN
Keywords
high-flow nasal cannula; newborn infant; noninvasive ventilation; respiratory distress
Citation
PEDIATRICS AND NEONATOLOGY, v.61, no.2, pp.174 - 179
Indexed
SCIE
SCOPUS
Journal Title
PEDIATRICS AND NEONATOLOGY
Volume
61
Number
2
Start Page
174
End Page
179
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/56716
DOI
10.1016/j.pedneo.2019.09.004
ISSN
1875-9572
Abstract
Background: Humidified high-flow nasal cannula (HHFNC) has gained popularity because it is easier to use, more comfortable for babies, and advantageous for mother-infant bonding. HHFNC is not inferior to other non-invasive ventilators for preventing adverse outcomes, but more studies are needed to ensure the safe use of HHFNC as an initial respiratory support for newborns. The aim of this study was to investigate risk factors for treatment failure of HHFNC as an initial respiratory support in newborns with respiratory distress after birth. Methods: We included 97 newborns who required non-invasive respiratory support within 24 h after birth. The success group included 68 infants who were successfully managed only on HHFNC, and 29 infants were the failure group who required other respiratory support because of respiratory acidosis, hypoxia, or apnea. Results: Compared with the success group, the failure group had lower GA, a higher rate of antenatal steroid use, prolonged rupture of membrane, lower pH, higher pCO(2) on blood-gas analysis after HHFNC application and higher incidence of respiratory distress syndrome of newborn (RDS). After adjusting for GA, higher FiO(2) settings during acidosis, hypercarbia after the application of HHFNC shown on blood-gas analysis and the presence of RDS remained significant. The rate of treatment failure was 16.2% for >= 36 weeks, 19.3% for >= 34 weeks, and 22.1% for >= 33 weeks. Conclusion: Treatment failure of HHFNC should be considered a risk for newborns of less than 34 weeks and infants with respiratory distress from RDS. Higher FiO(2) settings during HHFNC, and acidosis and hypercarbia after the application of HHFNC shown on blood-gas analysis may help identify high-risk newborns for other non-invasive ventilators or intubation. Copyright (C) 2019, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Choi, Byung Min photo

Choi, Byung Min
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE